| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |